Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IRLAB-THERAPEUTICS-AB-61747292/news/IRLAB-has-received-approval-from-the-Swedish-Medical-Products-Agency-to-conduct-a-Phase-I-study-of-t-46632890/?utm_source=whatsapp&utm_medium=social&utm_campaign=share